HOME >> MEDICINE >> NEWS
UCLA studies experimental cancer drug

Men with high-risk prostate cancer who are candidates for surgery are being sought to test a molecularly targeted experimental drug that may interrupt the signal that is driving their cancer and keep the disease from recurring.

The early-phase clinical trial is based on basic research discoveries made in Jonsson Cancer Center laboratories. UCLA researchers have successfully tested the drug in laboratory and animal models. They hope to translate that benefit into patients in the clinic, said Dr. Charles Sawyers, co-principal investigator for the study and the Jonsson Cancer Center scientist whose basic research resulted in the clinical trial.

UCLA laboratory studies have shown that some patients with prostate cancer have lost PTEN, a tumor-suppressor gene. In some patients who have lost PTEN, a gene called mTOR located downstream in the cell-signaling pathway gets turned on and may be driving the cancer. Sawyers, along with co-principal investigator Dr. Robert Reiter, will test a drug called CCI779, which they believe targets mTOR.

"We discovered that tumors missing PTEN seem to be very responsive to CCI779, and it's very clear at a molecular biology level why," Sawyers said. "When you've lost PTEN, mTOR activity gets turned up and tumors become dependent on it for their growth. So a drug that inhibits mTOR should impact the tumor cells but have no effect on the normal cells."

Armed with his laboratory discoveries, Sawyers proposed the prostate cancer study to Wyeth Pharmaceuticals, and the clinical trial was designed. UCLA's Jonsson Cancer Center is the only West Coast site offering this study. Other sites participating include MD Anderson Cancer Center in Texas and Fox Chase Cancer Center in Philadelphia, Sawyers said.

Because CCI779 targets only what is broken in the cancer cell, it is expected to cause very few side effects, Sawyers said.

UCLA researchers are seeking study volunteers with newly diagnosed prostate ca
'"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
4-Dec-2003


Page: 1 2

Related medicine news :

1. New studies suggest airborne SARS transmission is possible
2. New studies show mixed results on epilepsy drugs and birth defects
3. Brain imaging studies investigate pain reduction by hypnosis
4. Impact of scientific advances on drug studies and membrane research to be explored
5. Two studies find evidence that sunlight may have beneficial influence on cancer
6. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
7. Animal studies show stem cells might make biological pacemaker
8. Infants, children prefer sounds over pictures and only slowly become visually oriented, studies find
9. New studies on Ritalin and Alzheimers Disease highlight ACNP Annual Meeting
10. Gender and sex hormones affect the brains pain response and more, according to new studies
11. Analysis of tamoxifen studies reveals slight increase of stroke risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCLA studies experimental cancer drug

(Date:2/26/2015)... (PRWEB) February 26, 2015 A Beautiful ... The practice is offering the following 50 year celebration ... for their choice of Sonic Care Diamond Clean or ... $179 respectively). The cost is $2895 for the ... require more than ten treatment procedures are priced accordingly). ...
(Date:2/26/2015)... Texas (PRWEB) February 26, 2015 The ... enabled local pastor and Central Texas resident John Short to ... much, he has set out to climb Mt. Kilimanjaro, the ... help stop human trafficking. , Starting in his late 20s, ... and eventually his hip bones and sockets were bone on ...
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 26, 2015 ... Hemostat Industry is a professional and in-depth study ... Hemostat industry with a focus on the ... market research are Lawton Gmbh & Co.KG, Hu-Friedy, ... Shanghai Medical Instruments, Shuangyin, Shanghai Weirong Medical Equipment, ...
(Date:2/26/2015)... Claflin Medical Equipment , a Rhode Island based medical ... based medical equipment distributor, have announced a merger effective ... premier organizations that specialize in equipment and the logistics ... By combining forces, they can now cover the entire ... Claflin will gain even greater reach with their government ...
(Date:2/26/2015)... 2015 Growth in the men’s ... a EuroMonitor International Report that U.S. men’s grooming ... In response to the robust demand for precision ... a barbering program in partnership with internationally acclaimed ... salon. The proprietary curriculum features 10 signature barbering ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3Health News:Claflin Medical Equipment Announces Merger with Hospital Associates 2Health News:Bellus Academy Partners with Renowned Hairstylist D.J. Muldoon to Launch Signature Barbering Program 2
(Date:2/26/2015)... YORK , Feb. 26, 2015 ... Latin America is estimated at 2.4 ... said that population growth, government insurance, newly insured ... in the region and will continue to propel ... on torresearch into the market and interviews with ...
(Date:2/26/2015)... LONDON , February 26, 2015 ... release, please scroll to bottom . Investor-Edge ... Johnson (NYSE: JNJ ), Teva Pharmaceutical Industries ... (NASDAQ: ENDP ), Allergan Inc. (NYSE: ... DEPO ). Free research report on Johnson and Johnson ...
(Date:2/26/2015)... 2015 Ultrasound World will celebrate its ... Hilton to provide the latest advances, trends, and ... from around the world. UE Systems ... in the field of air- and structure-borne ultrasound ... with this year,s conference. As with previous conference ...
Breaking Medicine Technology:Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2
Cached News: